Ispire Technology Inc. Reports Financial Results for the Fiscal First Quarter 2024
Ryan Allway
November 14th, 2023
News, Top News, Top Story
Overall Revenue Increased 59.1% to $42.9 Million; Gross Profit Increased 43.7% to $6.9 Million.
Revenue from cannabis vaping products up 116.8% to $17.3 Million
Revenue from tobacco vaping products up 34.8% to $25.5 Million.
LOS ANGELES, Nov. 14, 2023 /PRNewswire/ — Ispire Technology Inc. (“Ispire” or “the Company”) (NASDAQ: ISPR), a leader in vapor technology, providing high-quality, innovative products, announced today reported financial results for the fiscal first quarter 2024, which ended on September 30, 2023, and filed its quarterly report on Form 10-Q on November 14, 2023.
Fiscal First Quarter 2024 Financial Results
- Revenue increased 59.1% to $42.9 million as compared to $26.9 million in the same period of 2023. Tobacco vaping products contributed $25.5 million and cannabis vaping products contributed $17.3 million to revenue during the fiscal first quarter 2024;
- Gross profit increased 43.7% to $6.9 million as compared to $4.8 million in the same period of 2023;
- Gross margin decreased to 16.1% as compared to 17.8% in the same period of 2023;
- Total operating expenses increased 29.8% to $7.8 million as compared to $6.0 million in the same period of 2023; and
- Net loss of $1.4 million as compared to net loss of $2.0 million in the same period of 2023.
Michael Wang, Co-Chief Executive Officer of Ispire commented, “For the fiscal first quarter of 2024, we continued to deliver strong financial results as our overall revenues increased 59.1% year-over-year with cannabis and tobacco vaping product revenues increasing 116.8% and 34.8% as compared to the same periods the previous year. This increase reflects our strategic U.S. market expansion and the market’s warm reception to our best-in-class products. Our active presence at industry trade shows has been highlighted by the unveiling of our latest innovative product, the Ispire ONE™ which has transformed vaping experiences and set new standards in consumer safety and operational efficiency. Our business strategy has clearly manifested as we continue to redefine the vaping experience, consistently delivering high-quality and groundbreaking products that align with customer preferences.”
“We remain confident in our ability to maintain our position as the leading premier precision dosing technology company as we’ve not only secured our position in existing markets but have also made inroads into new geographies, adapting swiftly to increased market demands. The establishment of a new manufacturing facility in Malaysia marks a strategic step into the Southeast Asian market, signaling our readiness for scalable operations. As we progress through the fiscal year, we are on track to not only meet but also exceed our revenue projections for both cannabis and tobacco vaping products.” concluded Wang.
Daniel Machock, Chief Financial Officer of Ispire, added, “In the fiscal first quarter of 2024, Ispire’s revenue trajectory continued to ascend, with cannabis vaping products generating $17.3 million, up from $8.0 million for the same period last year, and tobacco vaping products revenues climbing to $25.5 million from $18.9 million for the same period last year. The continued successful execution of our business strategy has yielded fruitful results both financially and operationally that reflect our brand’s growing prominence as well as the strategic moves we’ve undertaken. As we continue to balance growth with operational efficiency, we remain committed to financial discipline while further driving shareholder value.”
Liquidity and Capital Resources
As of September 30, 2023, Ispire had cash and cash equivalents of $25.7 million and working capital of $27.6 million.
The Company believes that its current cash and cash flows provided by operating activities, and the net proceeds from the initial public offering will be sufficient to meet its working capital needs in the next 12 months.
Fiscal Year 2024 Outlook
Ispire is providing the following outlook for the cannabis and tobacco vaping products for fiscal year 2024, which ends on June 30, 2024. Revenue for cannabis vaping products for fiscal year 2024 is projected at somewhere between $80 million and $90 million, representing growth between 100% and 125% from fiscal year 2023. Revenue for tobacco vaping products for fiscal year 2024 is projected at somewhere between $100 million and $110 million, representing growth between 33% and 47% from fiscal year 2023.
Conference Call
The Company will conduct a conference call at 8:00 a.m. Eastern time on Tuesday, November 14, 2023, to discuss the results.
Ispire management will host the conference call, followed by a question-and-answer period.
Date: Tuesday, November 14, 2023
Time: 8:00 a.m. Eastern time
Toll-free dial-in number:
United States: 1-888-346-8982
Mainland China: 4001-201203
Hong Kong: 800-905945
International: 1-412-902-4272
Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=pzOaTzRt
Please call the conference call dial-in 5-10 minutes prior to the start time, and ask for the “Ispire Technology Call.” An operator will register your name and organization.
To be added to the Ispire Technology email distribution list, please email ispire@kcsa.com with ISPR in the subject line.
About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The Company’s operating subsidiaries own or license from a related party more than 200 patents received or filed globally. Ispire’s tobacco products are marketed under the Aspire brand name and are sold worldwide (except in the United States, People’s Republic of China, and Russia) primarily through its distribution network. Ispire’s cannabis products are marketed under the Ispire brand name primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies. Ispire currently sells its cannabis vaping hardware only in the United States, and it recently commenced marketing activities in Canada and Europe, primarily in the European Union.
Please visit www.ispiretechnology.com and follow us on Facebook, Twitter, Instagram, Linkedin, Pinterest, and YouTube. Any information contained on, or that can be accessed through, the Company’s website, any other website or any social media, is not a part of this press release.
Forward Looking Statements
This press release and the conference call described in this press release contains and will contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,” “future,” “likely” or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company’s strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company’s ability to collect its accounts receivable in a timely manner, the Company’s business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE™’s success if meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Cautionary Note on Forward-Looking Statements” and the additional risk described in Ispire’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 and any subsequent filings which Ispire makes with the Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.
Investor Relations Contact:
Sherry Zheng
718.213.7386
ir@ispiretechnology.com
|
ISPIRE TECHNOLOGY INC. |
||||||||
|
CONSOLIDATED BALANCE SHEETS |
||||||||
|
June 30, |
September 30, |
|||||||
|
2023 |
2023 |
|||||||
|
Assets |
||||||||
|
Current assets: |
||||||||
|
Cash and cash equivalents |
$ |
40,300,573 |
$ |
25,686,052 |
||||
|
Accounts receivable, net |
24,526,262 |
39,160,751 |
||||||
|
Inventories, net |
7,472,108 |
5,609,028 |
||||||
|
Prepaid expenses and other current assets |
3,378,617 |
1,964,822 |
||||||
|
Held-to-maturity investment |
9,133,707 |
9,192,746 |
||||||
|
Total current assets |
84,811,267 |
81,613,399 |
||||||
|
Other assets: |
||||||||
|
Property, plant and equipment, net |
1,088,131 |
1,592,092 |
||||||
|
Intangible assets |
– |
255,650 |
||||||
|
Rental deposit |
732,334 |
660,282 |
||||||
|
Right-of-use assets – operating leases |
4,061,617 |
4,285,182 |
||||||
|
Total other assets |
5,882,082 |
6,793,206 |
||||||
|
Total assets |
$ |
90,693,349 |
$ |
88,406,605 |
||||
|
Liabilities and stockholders’ equity |
||||||||
|
Current liabilities |
||||||||
|
Accounts payable |
$ |
1,274,391 |
$ |
170,507 |
||||
|
Accounts payable – related party |
51,698,588 |
50,504,883 |
||||||
|
Contract liabilities |
988,556 |
1,290,061 |
||||||
|
Accrued liabilities and other payables |
281,361 |
273,745 |
||||||
|
Due to related parties |
710,910 |
– |
||||||
|
Income tax payable – current |
63,853 |
559,991 |
||||||
|
Operating lease liabilities – current portion |
944,525 |
1,207,234 |
||||||
|
Total current liabilities |
55,962,184 |
54,006,421 |
||||||
|
Other liabilities: |
||||||||
|
Operating lease liabilities – net of current portion |
3,356,232 |
3,387,844 |
||||||
|
Total liabilities |
$ |
59,318,416 |
$ |
57,394,265 |
||||
|
Stockholders’ equity: |
||||||||
|
Common stock, par value $0.0001 per share; 140,000,000 shares authorized; |
5,422 |
5,427 |
||||||
|
Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized, no |
– |
– |
||||||
|
Equity reserve |
– |
641,943 |
||||||
|
Additional paid-in capital |
25,685,475 |
26,011,086 |
||||||
|
Accumulated other comprehensive loss |
(163,768) |
(119,305) |
||||||
|
Retained earnings |
5,847,804 |
4,473,189 |
||||||
|
Total stockholders’ equity |
31,374,933 |
31,012,340 |
||||||
|
Total liabilities and stockholders’ equity |
$ |
90,693,349 |
$ |
88,406,605 |
||||
|
ISPIRE TECHNOLOGY INC. |
||||||||
|
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS |
||||||||
|
Three Months Ended |
||||||||
|
2022 |
2023 |
|||||||
|
Revenue |
$ |
26,943,050 |
$ |
42,864,647 |
||||
|
Cost of revenue |
22,150,947 |
35,976,355 |
||||||
|
Gross profit |
4,792,103 |
6,888,292 |
||||||
|
Operating expenses: |
||||||||
|
Sales and marketing expenses |
1,501,156 |
1,068,663 |
||||||
|
General and administrative expenses |
4,505,815 |
6,730,902 |
||||||
|
Total operating expenses |
6,006,971 |
7,799,565 |
||||||
|
Loss from operations |
(1,214,868) |
(911,273) |
||||||
|
Other income (expense): |
||||||||
|
Interest income |
510 |
72,246 |
||||||
|
Exchange gain (loss), net |
(500,794) |
3,661 |
||||||
|
Other income (expenses), net |
(19,201) |
(43,204) |
||||||
|
Total other income (expense), net |
(519,485) |
32,703 |
||||||
|
Loss before income taxes |
(1,734,353) |
(878,570) |
||||||
|
Income taxes – current |
(267,401) |
(496,045) |
||||||
|
Net loss |
$ |
(2,001,754) |
$ |
(1,374,615) |
||||
|
Other comprehensive (loss) income |
||||||||
|
Foreign currency translation adjustments |
(6,876) |
44,463 |
||||||
|
Comprehensive loss |
(2,008,630) |
(1,330,152) |
||||||
|
Net loss per share |
||||||||
|
Basic and diluted |
$ |
(0.04) |
$ |
(0.03) |
||||
|
Weighted average shares outstanding: |
||||||||
|
Basic and diluted |
50,000,000 |
54,246,212 |
||||||
|
ISPIRE TECHNOLOGY INC. |
||||||||
|
CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
|
Three Months ended |
||||||||
|
2022 |
2023 |
|||||||
|
Net loss: |
$ |
(2,001,754 |
) |
$ |
(1,374,615 |
) |
||
|
Adjustments to reconcile net income from operations to net cash provided by |
||||||||
|
Depreciation and amortization |
6,553 |
29,161 |
||||||
|
Depreciation of right-of-use assets |
256,655 |
312,938 |
||||||
|
Accounts receivable impairment |
– |
225,487 |
||||||
|
Stock-based compensation expenses |
– |
967,559 |
||||||
|
Changes in operating assets and liabilities: |
||||||||
|
Accounts receivable, net |
(5,917,620 |
) |
(14,710,476 |
) |
||||
|
Inventories |
(4,780,043 |
) |
1,863,080 |
|||||
|
Prepaid expenses and other current assets |
(24,810 |
) |
1,603,180 |
|||||
|
Accounts payable |
15,442,733 |
(2,449,276 |
) |
|||||
|
Contract liabilities |
(997,912 |
) |
281,529 |
|||||
|
Accrued liabilities and other payables |
(13,887 |
) |
(124,950 |
) |
||||
|
Income tax payable |
265,925 |
496,138 |
||||||
|
Net cash provided by (used in) operating activities |
$ |
2,235,840 |
$ |
(12,880,245 |
) |
|||
|
Cash flows from investing activities: |
||||||||
|
Purchase of property, plant and equipment |
(324,747 |
) |
(533,122 |
) |
||||
|
Acquisition of intangible assets |
– |
(255,650 |
) |
|||||
|
Net cash used in investing activities |
$ |
(324,747 |
) |
$ |
(788,772 |
) |
||
|
Cash flows from financing activities: |
||||||||
|
Advances to related parties |
(105,752 |
) |
(703,322 |
) |
||||
|
Principal portion of lease payment |
(185,600 |
) |
(242,182 |
) |
||||
|
Net cash used in financing activities |
$ |
(291,352 |
) |
$ |
(945,504 |
) |
||
|
Net increase(decrease) in cash and cash equivalents |
1,619,741 |
(14,614,521 |
) |
|||||
|
Cash and cash equivalents – beginning of period |
74,480,651 |
40,300,573 |
||||||
|
Cash and cash equivalents – end of period |
$ |
76,100,392 |
$ |
25,686,052 |
||||
SOURCE Ispire Technology Inc.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Innovium is a global beverage and foods brands platform that builds on consumer market trends and takes them to scale.
Jushi and its trade main administration crew is constructing a built-in multi-state proprietor and operator of cannabis and hemp licenses throughout America. Jushi is concentrated on persevering with to construct a various multi-state portfolio of branded cannabis and hemp-derived property by means of opportunistic investments and by internally pursuing licenses in enticing jurisdictions. Jushi strives […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
